Proteomic Profiling Identifies MARCO in Extracellular Vesicles, as a Potential Biomarker for Leishmaniasis in HIV Co-Infection
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26125691 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Inês Costa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal. Hauptthemen laut MEDLINE: Extracellular Vesicles, HIV Infections, Proteomics, Coinfection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, CIBER-Consorcio Centro de Investigación Biomédica en Red, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, and Unión Europea-NextGenerationEU; Ministerio de Ciencia e Innovación.
Abstract (Originalsprache)
Leishmania is an intracellular protozoan parasite that causes leishmaniasis, a disease prevalent in 97 countries. Co-infection with HIV increases susceptibility to visceral leishmaniasis (VL), accelerating HIV’s progression to AIDS. Managing VL in HIV-infected individuals is challenging due to atypical presentations and limited therapeutic responses, highlighting the need to develop new disease management strategies. Extracellular vesicles (EVs) hold great promise for this goal as they can be used for a higher understanding of biological processes and biomarker discovery. In this context, a proteomic analysis was carried out from plasma-EVs of an HIV/VL patient over two years and compared to HIV and healthy controls. The analysis confirmed classical EV markers but showed limited detection of Leishmania proteins. However, variations in human protein abundance related to relevant immunological processes were observed. Notably, the macrophage receptor with a collagenous structure (MARCO) was consistently detected only in the patient and not in the control groups. Significantly, the relevance of MARCO as a possible VL biomarker was confirmed using a validation cohort with five VL patients and its detection by Western Blot was possible. Although MARCO warrants further investigation as a VL related biomarker, the study of EVs confirmed their promise of being a privileged window into this disease. Future studies are needed to broaden data on EVs in infections to improve clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
- Laboratório de Microbiologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, 4200-135 Porto, Portugal.
- Departamento de Doenças Infeciosas, Centro Hospitalar e Universitário de São João, Faculdade de Medicina, Universidade do Porto, 4200-135 Porto, Portugal.
- Ipatimup-Instituto de Patologia e Imunologia Molecular da Universidade do Porto, 4200-135 Porto, Portugal.
- Departamento de Patologia, Faculdade de Medicina, Universidade do Porto, 4200-319 Porto, Portugal.
- ISGlobal, Barcelona Institute for Global Health, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), 08007 Barcelona, Spain.
ORCID-Profile: Inês Costa, Ana Isabel Pinto, Hugo Osório, Carmen Fernandez-Becerra
Förderung
- Fundação para a Ciência e Tecnologia
- CIBER-Consorcio Centro de Investigación Biomédica en Red
- Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, and Unión Europea-NextGenerationEU; Ministerio de Ciencia e Innovación
- AGAUR-SGR
- rtuguese Mass Spectrometry Network, integrated in the National Roadmap of Research Infra-structures of Strategic Relevance
- Portuguese Foundation for Science and Technology (FCT)
- FCT
- European Social Fund
Zitieren
APA
Costa, I., Pinto, A. I., Esteves, S., Caldas, C., Osório, H., Santarém, N., Fernandez-Becerra, C., & Cordeiro-da-Silva, A. (2025). Proteomic Profiling Identifies MARCO in Extracellular Vesicles, as a Potential Biomarker for Leishmaniasis in HIV Co-Infection. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125691
Vancouver
Costa I, Pinto AI, Esteves S, Caldas C, Osório H, Santarém N, et al. Proteomic Profiling Identifies MARCO in Extracellular Vesicles, as a Potential Biomarker for Leishmaniasis in HIV Co-Infection. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125691
BibTeX
@article{Costa2025,
author = {Costa, Inês and Pinto, Ana Isabel and Esteves, Sofia and Caldas, Cátia and Osório, Hugo and Santarém, Nuno and Fernandez-Becerra, Carmen and Cordeiro-da-Silva, Anabela},
title = {Proteomic Profiling Identifies MARCO in Extracellular Vesicles, as a Potential Biomarker for Leishmaniasis in HIV Co-Infection},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26125691}
}
EUVIMED